# PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer

> **NCT04151277** · PHASE2 · UNKNOWN · sponsor: **Judith Dixon-Hughes** · enrollment: 500 (estimated)

## Conditions studied

- Neoplasms Pancreatic

## Interventions

- **DRUG:** FOLFOX-A
- **DRUG:** Gemcitabe and Abraxane
- **DRUG:** G-CSF

## Key facts

- **NCT ID:** NCT04151277
- **Lead sponsor:** Judith Dixon-Hughes
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-28
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-01-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-02-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04151277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04151277, "PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04151277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*